In addition, ATG14 promotes platinum drugs and gemcitabine resistance in colorectal cancer, pancreatic cancer, ovarian cancer, and lung cancer (29, 32, 37, 60). This evidence concerns the gene ATG14 and familial pancreatic carcinoma.